Friday, 16 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 25, 2026

Oil Drops on Signs of US Diplomatic Push to End War With Iran

View original at finance.yahoo.com
Oil Drops on Signs of US Diplomatic Push to End War With Iran (Bloomberg) -- Oil fell on signals that a US diplomatic push to try to end the war with Iran may be gathering pace, eclipsing news of more troops being sent to the region and the Strait of Hormuz remaining mainly shut…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Washington was seeking a one-month ceasefire for talks with Iran

    60% confidence

  • Iran had offered a 'present' as a show of good faith in talks related to energy flows through the strait

    60% confidence

  • The US sent Iran a 15-point plan to end the conflict

    60% confidence

  • There was now a 'newfound possibility of diplomacy' but US military operations would continue unabated

    60% confidence

  • Trump appears to be seeking serious negotiations with Iran, while also keeping his options open

    60% confidence

  • Foreign ships are allowed to pass through Strait of Hormuz as long as they aren't supporting acts of aggression against Iran and follow Iranian regulations

    60% confidence

  • The pullback in oil prices reflects the war-risk premium being cut, but this is unlikely to be seen as an all-clear yet because Iran has publicly denied direct talks while military activity continues

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com
Oil Drops on Signs of US Diplomatic Push to End War With Iran — Source | Via News | ViaNews EU